Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: An update on stem cell therapies for acute coronary syndrome
Author: Psaltis, P.
Spoon, D.
Wong, D.
Gulati, R.
Citation: Current Cardiology Reports, 2014; 16(9):526-538
Publisher: Current Medicine Group
Issue Date: 2014
ISSN: 1534-3170
Statement of
Peter J. Psaltis, Daniel B. Spoon, Dennis T. L. Wong, Rajiv Gulati
Abstract: Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.
Keywords: Humans
Pluripotent Stem Cells
Myocardial Infarction
Treatment Outcome
Mesenchymal Stem Cell Transplantation
Bone Marrow Transplantation
Induced Pluripotent Stem Cells
Acute Coronary Syndrome
Endothelial Progenitor Cells
Rights: © Springer Science+Business Media New York 2014
DOI: 10.1007/s11886-014-0526-z
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.